← Back to Dashboard

Juluca

Integrase strand transfer inhibitor + NNRTI

Constituent drugs (2)

Dolutegravir

Could not render structureView on PubChem
3D not available

Rilpivirine

Could not render structureView on PubChem
3D not available

Chemical Identifiers

ClinicalTrials.govPubMed

Clinical Development by Virus1

Human immunodeficiency virus 1
HIV-1
Target: Viral integrase + RT
Approved (other)
Preclinical
Phase 2positive
Phase 3positive
Approved
Japan
Approval ref (pmda.go.jp) PMDA approved Nov. 26, 2018fixed-dose combination of Dolutegravir, Rilpivirine.